Wenxin Keli versus Sotalol for Paroxysmal Atrial Fibrillation Caused by Hyperthyroidism: A Prospective, Open Label, and Randomized Study

Table 5

Comparisons of thyroid hormones in patients before and after or ATD^* treatments in the first investigation.

Before treatments
	treatment (90 cases)	ATD^* treatment (90 cases)	value ( value)^**
FT3^* (pmol/L)	24.056 ± 5.321	24.964 ± 4.685	1.215 (0.226)
FT4^* (pmol/L)	117.633 ± 29.225	117.225 ± 28.322	−0.095 (0.924)
TSH^* (IU/mL)	0.007 ± 0.011	0.009 ± 0.014	0.757 (0.450)
Three months after treatments
	treatment (90 cases)	ATD^* treatment (90 cases)	value ( value)^**
FT3^* (pmol/L)	5.837 ± 2.830	7.252 ± 4.330	2.595 (0.010)
FT4^* (pmol/L)	19.378 ± 8.292	23.722 ± 13.120	2.655 (0.009)
TSH^* (IU/mL)	6.427 ± 9.702	5.539 ± 9.237	−0.629 (0.530)

ATD: antithyroid drugs, FT3: free triiodothyronine, FT4: free thyroxine, and TSH: thyroid stimulating hormone; ^**analyzed by independent samples -test.